A Prospective, Multi-Center, Randomized, Double Blind, Placebo-Controlled Trial Comparing Vitrogro® ECM To Placebo As An Adjunct To Standard Care In Patients With Venous Leg Ulcers
The objective of this study is to assess the efficacy and safety of VitroGro® combined with standard care in the treatment of Venous Leg Ulcers (VLUs) compared to Placebo with standard care over the course of the 8-week treatment phase.
100 项与 Tissue Therapies Europe Ltd. 相关的临床结果
0 项与 Tissue Therapies Europe Ltd. 相关的专利(医药)
100 项与 Tissue Therapies Europe Ltd. 相关的药物交易
100 项与 Tissue Therapies Europe Ltd. 相关的转化医学